Welcome to the new SimplyStockInfo.com

What was a passion has now turned into a small business. I started following the stock market in 2005 but it wasn’t till 2011 I started watching CNBC on a daily basis.  My goal is to provide a blog that consolidates stock market information for the

Portfolio Review – Healthcare – Actavis

The Schwab Profile – Actavis (ACT) (price of stock is $296.54 as of 6/9/15) is a global, integrated specialty pharmaceutical company. The Company focuses on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter

Video: Rare Interview with Johnson and Johnson CEO Alex Gorsky

Alex Gorsky,  CEO of Johnson and Johnson,  discusses new drugs in the company’s pipeline,  promising results in oncology  and defending the company’s franchise. http://video.cnbc.com/gallery/?video=3000381199   Part 1 http://video.cnbc.com/gallery/?video=3000381170  Part 2